Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ADMA Biologics Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ADMA
Nasdaq
2836
https://www.admabiologics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ADMA Biologics Inc
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
- Apr 17th, 2024 9:50 pm
Are Medical Stocks Lagging Annexon (ANNX) This Year?
- Apr 17th, 2024 1:40 pm
GSK Announces FDA Acceptance of New Meningococcal Jab BLA
- Apr 17th, 2024 12:14 pm
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why
- Apr 16th, 2024 4:47 pm
Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study
- Apr 16th, 2024 3:46 pm
J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
- Apr 16th, 2024 2:53 pm
Adma Biologics (ADMA) Suffers a Larger Drop Than the General Market: Key Insights
- Apr 10th, 2024 9:45 pm
Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study
- Apr 10th, 2024 2:59 pm
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
- Apr 9th, 2024 5:34 pm
Is it a Good Idea to Invest in ADMA Biologics (ADMA) Stock Now?
- Apr 9th, 2024 3:07 pm
Palatin (PTN) Up 15% on Results From Dry Eye Disease Study
- Apr 9th, 2024 12:59 pm
Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised)
- Apr 9th, 2024 3:38 am
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
- Apr 8th, 2024 5:27 pm
AstraZeneca's (AZN) Enhertu Gets FDA Nod for Solid Tumors
- Apr 8th, 2024 1:21 pm
J&J's (JNJ) $13.1B Shockwave Deal to Boost MedTech Cardio
- Apr 8th, 2024 1:18 pm
Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable
- Apr 5th, 2024 12:50 pm
Gritstone (GRTS) Plummets 58% in a Week: Here's Why
- Apr 4th, 2024 5:32 pm
Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%
- Apr 4th, 2024 5:20 pm
Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug
- Apr 4th, 2024 9:36 am
EMA Accepts Rocket (RCKT) Gene Therapy Filing for Fanconi Anemia
- Apr 3rd, 2024 3:32 pm
Scroll